• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过参数功率估计加速蒙特卡罗功效研究。

Accelerating Monte Carlo power studies through parametric power estimation.

作者信息

Ueckert Sebastian, Karlsson Mats O, Hooker Andrew C

机构信息

Pharmacometrics Research Group, Department of Pharmaceutical Biosciences, Uppsala University, P.O. Box 591, 751 24, Uppsala, Sweden.

出版信息

J Pharmacokinet Pharmacodyn. 2016 Apr;43(2):223-34. doi: 10.1007/s10928-016-9468-y. Epub 2016 Mar 2.

DOI:10.1007/s10928-016-9468-y
PMID:26934878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4791488/
Abstract

Estimating the power for a non-linear mixed-effects model-based analysis is challenging due to the lack of a closed form analytic expression. Often, computationally intensive Monte Carlo studies need to be employed to evaluate the power of a planned experiment. This is especially time consuming if full power versus sample size curves are to be obtained. A novel parametric power estimation (PPE) algorithm utilizing the theoretical distribution of the alternative hypothesis is presented in this work. The PPE algorithm estimates the unknown non-centrality parameter in the theoretical distribution from a limited number of Monte Carlo simulation and estimations. The estimated parameter linearly scales with study size allowing a quick generation of the full power versus study size curve. A comparison of the PPE with the classical, purely Monte Carlo-based power estimation (MCPE) algorithm for five diverse pharmacometric models showed an excellent agreement between both algorithms, with a low bias of less than 1.2 % and higher precision for the PPE. The power extrapolated from a specific study size was in a very good agreement with power curves obtained with the MCPE algorithm. PPE represents a promising approach to accelerate the power calculation for non-linear mixed effect models.

摘要

由于缺乏封闭形式的解析表达式,估计基于非线性混合效应模型的分析效能具有挑战性。通常,需要采用计算密集型的蒙特卡罗研究来评估计划实验的效能。如果要获得完整的效能与样本量曲线,这尤其耗时。本文提出了一种利用备择假设理论分布的新型参数化效能估计(PPE)算法。PPE算法通过有限数量的蒙特卡罗模拟和估计来估计理论分布中未知的非中心参数。估计参数与研究规模呈线性比例关系,从而能够快速生成完整的效能与研究规模曲线。将PPE与针对五种不同药代动力学模型的经典纯蒙特卡罗效能估计(MCPE)算法进行比较,结果表明两种算法之间具有出色的一致性,PPE的偏差小于1.2%,精度更高。从特定研究规模外推得到的效能与通过MCPE算法获得的效能曲线非常吻合。PPE是一种加速非线性混合效应模型效能计算的有前景的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/4791488/deaade3a36a6/10928_2016_9468_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/4791488/c05f5891ad0d/10928_2016_9468_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/4791488/d3732bf2de60/10928_2016_9468_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/4791488/ff1582bea250/10928_2016_9468_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/4791488/deaade3a36a6/10928_2016_9468_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/4791488/c05f5891ad0d/10928_2016_9468_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/4791488/d3732bf2de60/10928_2016_9468_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/4791488/ff1582bea250/10928_2016_9468_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb8f/4791488/deaade3a36a6/10928_2016_9468_Fig4_HTML.jpg

相似文献

1
Accelerating Monte Carlo power studies through parametric power estimation.通过参数功率估计加速蒙特卡罗功效研究。
J Pharmacokinet Pharmacodyn. 2016 Apr;43(2):223-34. doi: 10.1007/s10928-016-9468-y. Epub 2016 Mar 2.
2
Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.参数和非参数总体方法:它们在分析临床数据集和两项蒙特卡罗模拟研究中的比较性能。
Clin Pharmacokinet. 2006;45(4):365-83. doi: 10.2165/00003088-200645040-00003.
3
Evaluation of the nonparametric estimation method in NONMEM VI.NONMEM VI中无参数估计方法的评估。
Eur J Pharm Sci. 2009 Apr 11;37(1):27-35. doi: 10.1016/j.ejps.2008.12.014. Epub 2008 Dec 30.
4
Applications of Monte Carlo Simulation in Modelling of Biochemical Processes蒙特卡罗模拟在生化过程建模中的应用
5
[The Monte Carlo method and parallel estimation in the drawing up of radiosurgery treatment plans].[蒙特卡罗方法与放射外科治疗计划制定中的并行估计]
Radiol Med. 1998 Jun;95(6):647-55.
6
Sample size and power calculations for medical studies by simulation when closed form expressions are not available.模拟时无法使用闭式表达式的医学研究的样本量和功效计算。
Stat Methods Med Res. 2013 Jun;22(3):324-45. doi: 10.1177/0962280212439578. Epub 2012 Apr 4.
7
Monte Carlo methods for light propagation in biological tissues.用于生物组织中光传播的蒙特卡罗方法。
Math Biosci. 2015 Nov;269:48-60. doi: 10.1016/j.mbs.2015.08.017. Epub 2015 Sep 8.
8
Assessing meta-regression methods for examining moderator relationships with dependent effect sizes: A Monte Carlo simulation.评估元回归方法以检验与依存效应大小的调节关系:一项蒙特卡罗模拟。
Res Synth Methods. 2017 Dec;8(4):435-450. doi: 10.1002/jrsm.1245. Epub 2017 May 28.
9
[Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters].[多次谷值采样设计与算法对群体及个体药代动力学参数估计的影响]
Yao Xue Xue Bao. 2014 May;49(5):686-94.
10
Sample size determination in two-sided distribution-free treatment versus control multiple comparisons.双侧非参数检验中治疗组与对照组多重比较的样本量确定
J Biopharm Stat. 2013;23(6):1308-29. doi: 10.1080/10543406.2013.834921.

引用本文的文献

1
Quantitative Comparisons of Progressive Supranuclear Palsy Rating Scale Versions Using Item Response Theory.使用项目反应理论对进行性核上性麻痹评定量表版本进行定量比较。
Mov Disord. 2024 Dec;39(12):2181-2189. doi: 10.1002/mds.30001. Epub 2024 Aug 29.
2
Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates.缺氧缺血性脑病新生儿别嘌醇、其活性代谢物氧嘌呤醇以及生物标志物次黄嘌呤、黄嘌呤和尿酸的药代动力学/药效学建模。
Clin Pharmacokinet. 2022 Feb;61(2):321-333. doi: 10.1007/s40262-021-01068-0. Epub 2021 Oct 7.
3

本文引用的文献

1
Influence of the Size of Cohorts in Adaptive Design for Nonlinear Mixed Effects Models: An Evaluation by Simulation for a Pharmacokinetic and Pharmacodynamic Model for a Biomarker in Oncology.非线性混合效应模型自适应设计中样本量的影响:针对肿瘤学生物标志物的药代动力学和药效学模型的模拟评估
Pharm Res. 2015 Oct;32(10):3159-69. doi: 10.1007/s11095-015-1693-3. Epub 2015 Jun 30.
2
Statistical power calculations for mixed pharmacokinetic study designs using a population approach.使用群体方法对混合药代动力学研究设计进行统计效能计算。
AAPS J. 2014 Sep;16(5):1110-8. doi: 10.1208/s12248-014-9641-4. Epub 2014 Jul 11.
3
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics.
Pharmacometrics-Based Considerations for the Design of a Pharmacogenomic Clinical Trial Assessing Irinotecan Safety.
基于药代动力学的考虑因素在设计评估伊立替康安全性的药物基因组学临床试验中的应用。
Pharm Res. 2021 Apr;38(4):593-605. doi: 10.1007/s11095-021-03024-w. Epub 2021 Mar 17.
4
Dose Correction for a Michaelis-Menten Approximation of a Target-Mediated Drug Disposition Model with a Multiple Intravenous Dosing Regimens.基于多静脉滴注方案的 Michaelis-Menten 型靶控药物处置模型的剂量校正。
AAPS J. 2020 Jan 16;22(2):30. doi: 10.1208/s12248-019-0410-2.
5
Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV.异烟肼、吡嗪酰胺和乙胺丁醇在南非妊娠合并结核和 HIV 妇女中的群体药代动力学。
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01978-19.
6
Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhage.脑出血改良 Rankin 量表和美国国立卫生研究院卒中量表神经结局的建模与模拟。
J Pharmacokinet Pharmacodyn. 2019 Oct;46(5):473-484. doi: 10.1007/s10928-019-09653-4. Epub 2019 Aug 29.
7
Lessons learned from IDeAl - 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials.从 IDeAl 中吸取的教训——IDeal-net 关于小人群临床试验设计和分析的 33 条建议。
Orphanet J Rare Dis. 2018 May 11;13(1):77. doi: 10.1186/s13023-018-0820-8.
8
A pharmacological rationale for improved everolimus dosing in oncology and transplant patients.在肿瘤学和移植患者中优化依维莫司给药的药理学原理。
Br J Clin Pharmacol. 2018 Jul;84(7):1575-1586. doi: 10.1111/bcp.13591. Epub 2018 May 6.
9
An automated sampling importance resampling procedure for estimating parameter uncertainty.一种用于估计参数不确定性的自动采样重要性重采样程序。
J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):509-520. doi: 10.1007/s10928-017-9542-0. Epub 2017 Sep 8.
10
Implications for Drug Characterization in Glucose Tolerance Tests Without Insulin: Simulation Study of Power and Predictions Using Model-Based Analysis.葡萄糖耐量试验中不使用胰岛素时药物特征分析的意义:基于模型分析的效能和预测模拟研究。
CPT Pharmacometrics Syst Pharmacol. 2017 Oct;6(10):686-694. doi: 10.1002/psp4.12214. Epub 2017 Sep 25.
评价 Bootstrap 方法在估计非线性混合效应模型中参数不确定性的应用:群体药代动力学中的模拟研究。
J Pharmacokinet Pharmacodyn. 2014 Feb;41(1):15-33. doi: 10.1007/s10928-013-9343-z. Epub 2013 Dec 8.
4
Optimizing disease progression study designs for drug effect discrimination.优化疾病进展研究设计以区分药物疗效。
J Pharmacokinet Pharmacodyn. 2013 Oct;40(5):587-96. doi: 10.1007/s10928-013-9331-3. Epub 2013 Aug 27.
5
Rapid sample size calculations for a defined likelihood ratio test-based power in mixed-effects models.基于似然比检验的混合效应模型中特定功效的快速样本量计算。
AAPS J. 2012 Jun;14(2):176-86. doi: 10.1208/s12248-012-9327-8. Epub 2012 Feb 17.
6
Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database.阿尔茨海默病神经影像学倡议数据库中认知恶化的疾病进展模型。
Alzheimers Dement. 2011 Mar;7(2):151-60. doi: 10.1016/j.jalz.2010.03.018. Epub 2010 Sep 1.
7
Disease progression meta-analysis model in Alzheimer's disease.阿尔茨海默病疾病进展的荟萃分析模型。
Alzheimers Dement. 2010 Jan;6(1):39-53. doi: 10.1016/j.jalz.2009.05.665. Epub 2009 Jul 9.
8
Model-based drug development.基于模型的药物研发。
Clin Pharmacol Ther. 2007 Jul;82(1):21-32. doi: 10.1038/sj.clpt.6100235. Epub 2007 May 23.
9
Design in nonlinear mixed effects models: optimization using the Fedorov-Wynn algorithm and power of the Wald test for binary covariates.非线性混合效应模型中的设计:使用费多罗夫 - 韦恩算法进行优化以及二元协变量的Wald检验功效
Stat Med. 2007 Dec 10;26(28):5162-79. doi: 10.1002/sim.2910.
10
PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.PsN工具包——一组使用NONMEM进行非线性混合效应建模的计算机密集型统计方法。
Comput Methods Programs Biomed. 2005 Sep;79(3):241-57. doi: 10.1016/j.cmpb.2005.04.005.